The tumor suppressor p53 is one of the most important proteins activated after DNA damage, and p53 gene mutations are described in almost every type of cancer, at rates comprised between 38% and 50% in ovarian, colorectal, head and neck, and lung cancers [27]. This evidence concerns the gene TP53 and lung carcinoma.